Difference between revisions of "Vasoactive intestinal peptide"
(New page: {{subst:infobox}}) |
|||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| Line 9: | Line 8: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | VIP |
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Extracellular; Secreted |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| Line 24: | Line 23: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | Q16 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | | + | | K21 |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| Line 33: | Line 32: | ||
|- | |- | ||
| Structure | | Structure | ||
| − | | | + | | No available crystal structure |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 41: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=10408336&dopt=Abstract PMID:10408336] |
|- | |- | ||
| Notes | | Notes | ||
Revision as of 06:54, 24 July 2007
| Template:Infobox header| Vasoactive intestinal peptide | |
|---|---|
| Vasoactive intestinal peptide | |
| Substrate peptide name | Vasoactive intestinal peptide |
| Synonyms | VIP |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; Secreted |
| Swissprot ID | P08865 |
| Reactive glutamines | Q16 |
| Reactive lysines | K21 |
| Substrate sequence | GRPRHQGVMVG |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10408336 |
| Notes | |
| Template:Infobox header | | |
